The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Rossella Elisei

Department of Endocrinology

University of Pisa

Via Paradisa 2

56124 Pisa

Italy

[email]@*.med.unipi.it

Name/email consistency: high

 
 
 
 
 
 
 

Affiliation

  • Department of Endocrinology, University of Pisa, Via Paradisa 2, 56124 Pisa, Italy. 2000 - 2012

References

  1. Modifications in the papillary thyroid cancer gene profile over the last 15 years. Romei, C., Fugazzola, L., Puxeddu, E., Frasca, F., Viola, D., Muzza, M., Moretti, S., Luisa Nicolosi, M., Giani, C., Cirello, V., Avenia, N., Rossi, S., Vitti, P., Pinchera, A., Elisei, R. J. Clin. Endocrinol. Metab. (2012) [Pubmed]
  2. The Timing of Total Thyroidectomy in RET Gene Mutation Carriers Could Be Personalized and Safely Planned on the Basis of Serum Calcitonin: 18 Years Experience at One Single Center. Elisei, R., Romei, C., Renzini, G., Bottici, V., Cosci, B., Molinaro, E., Agate, L., Cappagli, V., Miccoli, P., Berti, P., Faviana, P., Ugolini, C., Basolo, F., Vitti, P., Pinchera, A. J. Clin. Endocrinol. Metab. (2012) [Pubmed]
  3. Are the clinical and pathological features of differentiated thyroid carcinoma really changed over the last 35 years? Study on 4187 patients from a single Italian institution to answer this question. Elisei, R., Molinaro, E., Agate, L., Bottici, V., Masserini, L., Ceccarelli, C., Lippi, F., Grasso, L., Basolo, F., Bevilacqua, G., Miccoli, P., Di Coscio, G., Vitti, P., Pacini, F., Pinchera, A. J. Clin. Endocrinol. Metab. (2010) [Pubmed]
  4. Follow-up of low-risk differentiated thyroid cancer patients who underwent radioiodine ablation of postsurgical thyroid remnants after either recombinant human thyrotropin or thyroid hormone withdrawal. Elisei, R., Schlumberger, M., Driedger, A., Reiners, C., Kloos, R.T., Sherman, S.I., Haugen, B., Corone, C., Molinaro, E., Grasso, L., Leboulleux, S., Rachinsky, I., Luster, M., Lassmann, M., Busaidy, N.L., Wahl, R.L., Pacini, F., Cho, S.Y., Magner, J., Pinchera, A., Ladenson, P.W. J. Clin. Endocrinol. Metab. (2009) [Pubmed]
  5. Routine serum calcitonin measurement in the evaluation of thyroid nodules. Elisei, R. Best Pract. Res. Clin. Endocrinol. Metab. (2008) [Pubmed]
  6. Prognostic significance of somatic RET oncogene mutations in sporadic medullary thyroid cancer: a 10-year follow-up study. Elisei, R., Cosci, B., Romei, C., Bottici, V., Renzini, G., Molinaro, E., Agate, L., Vivaldi, A., Faviana, P., Basolo, F., Miccoli, P., Berti, P., Pacini, F., Pinchera, A. J. Clin. Endocrinol. Metab. (2008) [Pubmed]
  7. BRAF(V600E) mutation and outcome of patients with papillary thyroid carcinoma: a 15-year median follow-up study. Elisei, R., Ugolini, C., Viola, D., Lupi, C., Biagini, A., Giannini, R., Romei, C., Miccoli, P., Pinchera, A., Basolo, F. J. Clin. Endocrinol. Metab. (2008) [Pubmed]
  8. RET genetic screening in patients with medullary thyroid cancer and their relatives: experience with 807 individuals at one center. Elisei, R., Romei, C., Cosci, B., Agate, L., Bottici, V., Molinaro, E., Sculli, M., Miccoli, P., Basolo, F., Grasso, L., Pacini, F., Pinchera, A. J. Clin. Endocrinol. Metab. (2007) [Pubmed]
  9. Treatment with drugs able to reduce iodine efflux significantly increases the intracellular retention time in thyroid cancer cells stably transfected with sodium iodide symporter complementary deoxyribonucleic acid. Elisei, R., Vivaldi, A., Ciampi, R., Faviana, P., Basolo, F., Santini, F., Traino, C., Pacini, F., Pinchera, A. J. Clin. Endocrinol. Metab. (2006) [Pubmed]
  10. All-trans-retinoic acid treatment inhibits the growth of retinoic acid receptor beta messenger ribonucleic acid expressing thyroid cancer cell lines but does not reinduce the expression of thyroid-specific genes. Elisei, R., Vivaldi, A., Agate, L., Ciampi, R., Molinaro, E., Piampiani, P., Romei, C., Faviana, P., Basolo, F., Miccoli, P., Capodanno, A., Collecchi, P., Pacini, F., Pinchera, A. J. Clin. Endocrinol. Metab. (2005) [Pubmed]
  11. RET/PTC3 rearrangement and thyroid differentiation gene analysis in a struma ovarii fortuitously revealed by elevated serum thyroglobulin concentration. Elisei, R., Romei, C., Castagna, M.G., Lisi, S., Vivaldi, A., Faviana, P., Marinò, M., Ceccarelli, C., Pacini, F., Pinchera, A. Thyroid (2005) [Pubmed]
  12. Low specificity of blood thyroglobulin messenger ribonucleic acid assay prevents its use in the follow-up of differentiated thyroid cancer patients. Elisei, R., Vivaldi, A., Agate, L., Molinaro, E., Nencetti, C., Grasso, L., Pinchera, A., Pacini, F. J. Clin. Endocrinol. Metab. (2004) [Pubmed]
  13. Impact of routine measurement of serum calcitonin on the diagnosis and outcome of medullary thyroid cancer: experience in 10,864 patients with nodular thyroid disorders. Elisei, R., Bottici, V., Luchetti, F., Di Coscio, G., Romei, C., Grasso, L., Miccoli, P., Iacconi, P., Basolo, F., Pinchera, A., Pacini, F. J. Clin. Endocrinol. Metab. (2004) [Pubmed]
  14. RET exon 11 (G691S) polymorphism is significantly more frequent in sporadic medullary thyroid carcinoma than in the general population. Elisei, R., Cosci, B., Romei, C., Bottici, V., Sculli, M., Lari, R., Barale, R., Pacini, F., Pinchera, A. J. Clin. Endocrinol. Metab. (2004) [Pubmed]
  15. Identification of a novel point mutation in the RET gene (Ala883Thr), which is associated with medullary thyroid carcinoma phenotype only in homozygous condition. Elisei, R., Cosci, B., Romei, C., Agate, L., Piampiani, P., Miccoli, P., Berti, P., Basolo, F., Ugolini, C., Ciampi, R., Nikiforov, Y., Pinchera, A. J. Clin. Endocrinol. Metab. (2004) [Pubmed]
  16. New breakpoints in both the H4 and RET genes create a variant of PTC-1 in a post-Chernobyl papillary thyroid carcinoma. Elisei, R., Romei, C., Soldatenko, P.P., Cosci, B., Vorontsova, T., Vivaldi, A., Basolo, F., Cherstvoy, E.D., Pinchera, A., Pacini, F. Clin. Endocrinol. (Oxf) (2000) [Pubmed]
 
WikiGenes - Universities